Promising Epigenetic Biomarkers Associated With Cancer-Associated-Fibroblasts for Progression of Kidney Renal Clear Cell Carcinoma
Kidney renal clear cell carcinoma (KIRC) is the most common malignant kidney tumor as its characterization of highly metastatic potential. Patients with KIRC are associated with poor clinical outcomes with limited treatment options. Up to date, the underlying molecular mechanisms of KIRC pathogenesi...
Main Authors: | Yongke You, Yeping Ren, Jikui Liu, Jianhua Qu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-09-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fgene.2021.736156/full |
Similar Items
-
Identification of a Novel Epigenetic Signature CHFR as a Potential Prognostic Gene Involved in Metastatic Clear Cell Renal Cell Carcinoma
by: Xiangling Chen, et al.
Published: (2021-09-01) -
The epigenetic landscape of clear-cell renal cell carcinoma
by: Katarzyna Kluzek, et al.
Published: (2015-05-01) -
The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments
by: Javier C. Angulo, et al.
Published: (2021-04-01) -
Zeta-crystallin serves as a prognostic biomarker for patients with kidney renal clear cell carcinoma
by: Xu Shi, et al.
Published: (2023-07-01) -
Roles of Epigenetics in Cardiac Fibroblast Activation and Fibrosis
by: Jingrong Shao, et al.
Published: (2022-07-01)